Glucose Regulation Disorders & Pancreatic Internal Secretion – ICD 11
Exclusions:
- Benign neoplasm of endocrine pancreas (2E92.9)
- Multiple endocrine neoplasia type 1 (2F7A.0)
- Malignant neoplasm of pancreas (2C10)
Coded Elsewhere:
- Somatostatinoma (2C10.1)
- VIPoma (2C10.1)
- PPoma (2C10.1)
- GRFoma (2C10.1)
Intermediate hyperglycaemia
Definition of Intermediate hyperglycaemia: A metabolic disorder characterised by glucose levels too high to be considered normal, though not high enough to meet the criteria for diabetes.
ICD 11 Code For Intermediate hyperglycaemia
5A40 Intermediate hyperglycaemia
Inclusions:
- prediabetes
- Impaired glucose regulation
Exclusions:
- Diabetes mellitus, other specified type (5A13)
- Idiopathic Type 1 diabetes mellitus (5A10)
- Type 2 diabetes mellitus (5A11)
- Diabetes mellitus, type unspecified (5A14)
- Elevated blood glucose level (MA18.0)
5A40.0 Impaired fasting glucose
Definition of Impaired fasting glucose: Impaired glucose tolerance is a metabolic disorder with FPG 110–125 mg/dl (6.1–6.9 mmol/l).
5A40.1 Impaired glucose tolerance
Definition of Impaired glucose tolerance: Impaired glucose tolerance (IGT) is a metabolic disorder, which is characterised by 2-h postload glucose 140–199 mg/dl (7.8–11.1 mmol/l).
5A40.Y Other specified intermediate hyperglycaemia
5A40.Z Intermediate hyperglycaemia unspecified
Hypoglycaemia without associated diabetes
ICD 11 Code For Hypoglycaemia without associated diabetes
5A41 Hypoglycaemia without associated diabetes
Exclusions:
- Hypoglycaemia in the context of diabetes mellitus (5A21)
Coded Elsewhere:
- Neonatal hypoglycaemia (KB60.4)
Increased secretion of glucagon
ICD 11 Code For Increased secretion of glucagon
5A42 Increased secretion of glucagon
Exclusions:
- Multiple endocrine neoplasia type 1 (2F7A.0)
Coded Elsewhere:
- Glucagonoma (2C10.1)
Abnormal secretion of gastrin
ICD 11 Code For Abnormal secretion of gastrin
5A43 Abnormal secretion of gastrin
Coded Elsewhere:
- Gastrinoma (2C10.1)
5A43.0 Drug-induced hypergastrinaemia
Definition of Drug-induced hypergastrinaemia: A form of hypergastrinaemia that can be induced by drugs.
5A43.1 Zollinger-Ellison syndrome
Definition of Zollinger-Ellison syndrome: A syndrome characterised by the presence of a gastrin-secreting tumour, usually in the pancreas or duodenum, resulting in increased gastric acidity and formation of gastric ulcers. Signs and symptoms include abdominal pain and diarrhea. It may be sporadic or a manifestation of multiple endocrine neoplasia type 1.
Coded Elsewhere:
- Anastomotic ulcer due to Zollinger-Ellison syndrome (DA62.Y)
- Gastric ulcer due to Zollinger-Ellison syndrome (DA60.Y)
- Duodenal ulcer due to Zollinger-Ellison syndrome (DA63.Y)
5A43.Y Other specified abnormal secretion of gastrin
5A43.Z Abnormal secretion of gastrin unspecified
Insulin-resistance syndromes
ICD 11 Code For Insulin-resistance syndromes
5A44 Insulin-resistance syndromes
Coding Note:
- Code also the causing condition
Persistent hyperinsulinaemic hypoglycaemia of infancy
Definition of Persistent hyperinsulinaemic hypoglycaemia of infancy: Congenital isolated hyperinsulinism, or Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) is defined by an inappropriate oversecretion of insulin by the endocrine pancreas that is responsible for profound hypoglycaemia, which requires aggressive medical and/or surgical treatment to prevent severe and irreversible brain damage. PHHI is a genetically heterogeneous disorder with two types of histological lesions: diffuse (DiPHHI) and focal (FoPHHI) which are clinically indistinguishable.
ICD 11 Code For Persistent hyperinsulinaemic hypoglycaemia of infancy
5A45 Persistent hyperinsulinaemic hypoglycaemia of infancy
Other specified disorders of glucose regulation and pancreatic internal secretion
ICD 11 Code For Other specified disorders of glucose regulation and pancreatic internal secretion
5A4Y Other specified disorders of glucose regulation and pancreatic internal secretion
Disorders of glucose regulation and pancreatic internal secretion unspecified
ICD 11 Code For Disorders of glucose regulation and pancreatic internal secretion unspecified
5A4Z Disorders of glucose regulation and pancreatic internal secretion unspecified
